EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

ApoE4 and Psychosis in Neurodegenerative and Non-Neurodegenerative Disease: A Scoping Review

Veronica Wasef, Neda Rashidi-Ranjbar, Nathan W. Churchill, Luis R. Fornazzari, Vincenzo De Luca, Simon J. Graham, David G. Munoz, Tom A. Schweizer, Corinne E. Fischer

International Journal of Molecular Sciences · 18.11.2026 · 27 (22) · 10337

DOI: 10.3390/ijms272210337 ↗

Kurz gefasst

Scoping Review in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.11.2026. Verfasst von Veronica Wasef und 8 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heather and Eric Donnelly Endowment, St. Michaels Hospital Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychosis is a neuropsychiatric feature found across neurodegenerative conditions including Alzheimer’s disease (AD) and Parkinson’s disease (PD). It is also a common feature in psychiatric disorders such as schizophrenia. The apolipoprotein E epsilon 4 (ApoE4) allele is an established genetic risk factor for AD that may also increase the risk of psychosis. However, evidence regarding the association between ApoE4 and psychosis remains unclear. This paper evaluates the relationship between ApoE4 carrier status and psychosis in both neurodegenerative (Alzheimer’s disease and Parkinson’s disease) and non-neurodegenerative disorders (schizophrenia). Additionally it explores whether sex and zygosity modulate this association. A literature review of studies identified through PubMed and Scopus was conducted. Thirty-one studies were included that investigated the relationship between ApoE4 and psychosis in select neurodegenerative and psychiatric populations. Studies were included if they assessed ApoE4 status in relation to the presence, severity, or age of onset of psychosis. Among the 16 AD-focused studies, a positive association was reported in 11 while four showed no significant association and one showed an inverse correlation. ApoE4 carriers and ApoE4 homozygotes that were female were reported to have the strongest association. The three studies examining PD resulted in inconsistent findings limited by small sample sizes. Schizophrenia studies produced findings that were predominantly null or equivocal, with no clear evidence that sex or zygosity influenced outcomes. Notably, the risk was enhanced in female carriers and ApoE4 homozygotes. Overall, ApoE4 positivity appears to be most consistent in AD, whereas evidence in PD and schizophrenia ae heterogeneous and limited, precluding direct comparison. Some studies suggest that this relationship may be modified by sex and ApoE4 zygosity, with female ApoE4 homozygotes being particularly vulnerable especially in AD cohorts. Larger studies are needed to clarify the role of ApoE4 in psychosis, particularly in non-AD cohorts.

Förderung

  • Heather and Eric Donnelly Endowment, St. Michaels Hospital Foundation

Zitieren

APA

Wasef, V., Rashidi-Ranjbar, N., Churchill, N. W., Fornazzari, L. R., Luca, V. D., Graham, S. J., Munoz, D. G., Schweizer, T. A., & Fischer, C. E. (2026). ApoE4 and Psychosis in Neurodegenerative and Non-Neurodegenerative Disease: A Scoping Review. International Journal of Molecular Sciences, 27(22), 10337. https://doi.org/10.3390/ijms272210337

Vancouver

Wasef V, Rashidi-Ranjbar N, Churchill NW, Fornazzari LR, Luca VD, Graham SJ, et al. ApoE4 and Psychosis in Neurodegenerative and Non-Neurodegenerative Disease: A Scoping Review. International Journal of Molecular Sciences. 2026;27(22):10337. doi:10.3390/ijms272210337

BibTeX
@article{Wasef2026,
  author = {Wasef, Veronica and Rashidi-Ranjbar, Neda and Churchill, Nathan W. and Fornazzari, Luis R. and Luca, Vincenzo De and Graham, Simon J. and Munoz, David G. and Schweizer, Tom A. and Fischer, Corinne E.},
  title = {ApoE4 and Psychosis in Neurodegenerative and Non-Neurodegenerative Disease: A Scoping Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10337},
  doi = {10.3390/ijms272210337}
}
Kostenlos starten →